Chronic leukemia is malignancy of mature hematopoietic cells.

Chronic myelogenous leukemia is caused by t(9;22) BCR-ABL.

BCR-ABL is a constitutively active tyrosine kinase.

Chronic myelogenous leukemia presents with splenomegaly and leukocytosis.

Imatinib inhibits BCR-ABL kinase.

Chronic lymphocytic leukemia is malignancy of mature B cells.

Smudge cells are characteristic of chronic lymphocytic leukemia.

Chronic lymphocytic leukemia is associated with autoimmune hemolytic anemia.
